Skip to main content
. 2021 Apr 7;23:103. doi: 10.1186/s13075-021-02486-y

Fig. 2.

Fig. 2

CCR2RA delivered systemically at different time points after DMM surgery. a 4, b 8, and c 16 weeks after DMM surgery, CCR2RA (RS504393, Tocris: 5 mg/kg, i.p., n = 5) or vehicle control (100% DMSO4, i.p., n = 4) was systemically administered and knee hyperalgesia was measured before injection, 1 h after, and 2 h after injection. **p < 0.01, ****p < 0.0001 vs vehicle. Repeated measures two-way ANOVA with Bonferroni’s multiple comparisons test to compare CCR2-RA to vehicle at each time point. Mean ± SEM